Real-time enrollment status for this locally advanced pancreatic adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:50 AM UTC
| NCT Number | NCT07157033 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced Pancreatic Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Xerient Pharma |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of July 13, 2026: Clinical trial NCT07157033 is currently recruiting participants. This clinical trial study for locally advanced pancreatic adenocarcinoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by Xerient Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07157033 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07157033 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.